Isagani (Gani) M. Chico, M.D.

VP and Global Head for Oncology

Fortrea

Talk to Gani about these topics and more:

  • Oncology clinical trials (early phase to post approval)
  • Oncology medical affairs
  • Pharmaceutical, academic and regulatory interactions

Biostatistics

Cell and Gene (CGT)

Clinical Data

Clinical Strategic Planning

Clinical Trial Retention

Clinical Trial Supply

Clinical Trial Technology

Clinical Trials

Communication Strategies

Contract Research Organization (CRO)

Corrective and preventive action (CAPA)

Decentralized Clinical Trials (DCTs)

Digital Health

Diversity

FDA

Healthcare

Licensing Strategies

M.D.

Patient Recruitment

Pharmacology 

Phase I/Early Phase Research 

Real-World Data

Regulatory

Research and Development

Research as Care

View Expert

John Doyle, DrPH

President, Consulting

Fortrea

Talk to John about these topics and more:

  • Tactics for driving health innovation
  • Optimizing market access strategies for new therapies
  • Demonstrating value through HEOR
  • Drug development life cycle strategies

Artificial Intelligence (AI)

Automation

Clinical Data

Communication Strategies

Corrective and preventive action (CAPA)

Decentralized Clinical Trials (DCTs)

Digital Health

Diversity

eCOA

FDA

Licensing Strategies

Machine Learning

Medical Writing

Patient Recruitment

Pharmacology 

Phase I/Early Phase Research 

Real-World Data

Regulatory

Research and Development

Risk Mitigation

Safety

Strategic Planning

View Expert

Robin Marcus

Head of Global Decentralized Trials Market Development

Marken

Talk to Robin about these topics and more: 

  • Optimizing and deploying patient-centric DCT services
  • Enhancing investigator site operations and reducing site burden
  • Ensuring high-quality biological sample collection and transport
  • Clinical research options for patient recruitment, adherence and retention
  • Strategies for addressing study challenges and recovering momentum

Clinical Trial Retention

Clinical Trial Supply

Clinical Trial Technology

Clinical Trials

Decentralized Clinical Trials (DCTs)

Diversity

eCOA

eSource

Healthcare

Marketing & Commercialization Strategy

Neurology

Packaging and Labeling

Paperless

Patient Recruitment

Real-World Data

Research and Development

Research as Care

Risk Mitigation

Supply Chain

Vaccines

Women's Health

View Expert

Rohin Iyer, Ph.D.

Senior Director Cell and Gene Operations

Marken

Talk to Rohin about these topics and more: 

  • Biomanufacturing & process development for cell & gene therapies 
  • Culture expansion of CAR-T cells, NK cells and mesenchymal stem cells 
  • Cold chain logistics and supply chain considerations for ATMPs 
  • Tissue engineering and regenerative medicine best practices 
  • Bioreactor development and scale-up/out  

Cell and Gene (CGT)

Next Generation Biotherapeutics

Research and Development

Supply Chain

View Expert

Tara Anne Kervin, MPH

VP Global Operations & Consulting

International Drug Development Institute (IDDI)

Talk to Tara about these topics and more: 

  • Independent Data Monitoring Committees (IDMCs; also known as Data and Safety Monitoring Boards [DSMBs])
  • Best practices in clinical data science and biometrics operations
  • Clinical trial design and interim analysis
  • Biostatistical consulting and regulatory interaction

Biopharmaceuticals

Biostatistics

Clinical Data

Clinical Neuropsychology

Clinical Trials

Contract Research Organization (CRO)

FDA

Phase I/Early Phase Research 

Programming

Regulatory

Research and Development

Safety

View Expert

Serge Bodart

Chief Commercial Officer

International Drug Development Institute (IDDI)

Talk to Serge about these topics and more: 

  • Best practices on implementation of eCOA in clinical trials
  • Marketing in life sciences
  • How to select the CRO that best suits your clinical trial

Biostatistics

Clinical Data

Clinical Research Organization (CRO)

eCOA

View Expert

Simmon Schaefer 

Global Key Accounts Director

Kindeva Drug Delivery

Talk to Simmon about these topics and more:  

  • CDMO collaboration
  • Inhalation drug delivery
  • Transdermal drug delivery
  • Life cycle management strategies

Clinical Data

Clinical Trials

Machine Learning

Preclinical

Programming

Real-World Data

Research and Development

View Expert

Oren Beske, Ph.D. 

Amalgamator of Business and Biology

ATUM

Talk to Dr. Beske about these topics and more: 

  • Cell line development 
  • Leap-In Transposase and Transposons 

Analytical Testing

Artificial Intelligence (AI)

Bioanalytical Testing

Biologics Manufacturing

Biopharmaceuticals

Cell and Gene (CGT)

CMC

Contract Development Manufacturing Organization (CDMO)

Contract Research Organization (CRO)

Large Molecules

Licensing Strategies

Machine Learning

Phase I/Early Phase Research 

Preclinical

Protein Purification

Quality

Research and Development

Vaccines

Viral Vector Development

View Expert

Claes Gustafsson, Ph.D. 

Chief Commercial Officer

ATUM

Talk to Dr. Gustafsson about these topics and more: 

  •  GPS Platform 
  • Protein Engineering 
  • AI Machine Learning 
  • Protein Analytics 

Analytical Testing

Artificial Intelligence (AI)

Bioanalytical Testing

Biologics Manufacturing

Biopharmaceuticals

Cell and Gene (CGT)

CMC

Contract Development Manufacturing Organization (CDMO)

Contract Research Organization (CRO)

Large Molecules

Licensing Strategies

Machine Learning

Phase I/Early Phase Research 

Preclinical

Protein Purification

Quality

Research and Development

Vaccines

Viral Vector Development

View Expert

Ella Balasa

Patient Advocate

Balasa Consulting

Talk to Ella about these topics and more: 

  • Understanding the patient journey throughout clinical trial involvement and clinical care
  • Patient engagement strategic planning
  • Disease campaign curation
  • Thought leadership, research summaries, and patient-facing materials for cystic fibrosis and rare disease

Cystic Fibrosis

Healthcare

Patient-engagement

Rare Disease

View Expert